Market open
iRadimed/$IRMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About iRadimed
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Ticker
$IRMD
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
160
Website
iRadimed Metrics
BasicAdvanced
$653M
34.24
$1.50
0.84
$0.62
1.32%
Price and volume
Market cap
$653M
Beta
0.84
52-week high
$63.29
52-week low
$40.18
Average daily volume
37K
Dividend rate
$0.62
Financial strength
Current ratio
8.776
Quick ratio
6.136
Long term debt to equity
0.002
Total debt to equity
0.178
Dividend payout ratio (TTM)
71.11%
Management effectiveness
Return on assets (TTM)
14.41%
Return on equity (TTM)
24.31%
Valuation
Price to earnings (TTM)
34.24
Price to revenue (TTM)
8.885
Price to book
7.5
Price to tangible book (TTM)
7.5
Price to free cash flow (TTM)
38.717
Dividend yield (TTM)
1.21%
Forward dividend yield
1.32%
Growth
Revenue change (TTM)
11.71%
Earnings per share change (TTM)
11.11%
3-year revenue growth (CAGR)
20.54%
3-year earnings per share growth (CAGR)
26.56%
What the Analysts think about iRadimed
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for iRadimed stock.
iRadimed Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
iRadimed Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
iRadimed News
AllArticlesVideos
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
GlobeNewsWire·4 weeks ago
IRADIMED CORPORATION (IRMD) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for iRadimed stock?
iRadimed (IRMD) has a market cap of $653M as of April 04, 2025.
What is the P/E ratio for iRadimed stock?
The price to earnings (P/E) ratio for iRadimed (IRMD) stock is 34.24 as of April 04, 2025.
Does iRadimed stock pay dividends?
Yes, the iRadimed (IRMD) stock pays dividends to shareholders. As of April 04, 2025, the dividend rate is $0.62 and the yield is 1.32%. iRadimed has a payout ratio of 71.11% on a trailing twelve-month basis.
When is the next iRadimed dividend payment date?
The next iRadimed (IRMD) dividend payment date is unconfirmed.
What is the beta indicator for iRadimed?
iRadimed (IRMD) has a beta rating of 0.84. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.